LENZ Therapeutics, Inc.LENZ Therapeutics, Inc.LENZ Therapeutics, Inc.

LENZ Therapeutics, Inc.

No trades
See on Supercharts

Price target

39.290.000.00%
The 7 analysts offering 1 year price forecasts for LENZ have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings to LENZ in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


LENZ EPS for the last quarter is −0.38 USD despite the estimation of −0.46 USD. In the next quarter EPS is expected to reach −0.41 USD. Track more of LENZ Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter LENZ Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out LENZ Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, LENZ price target is 39.29 USD with a max estimate of 44.00 USD and a min estimate of 36.00 USD. Check if this forecast comes true in a year, meanwhile watch LENZ Therapeutics, Inc. stock price chart and keep track of the current situation with LENZ news and stock market news.
We've gathered opinions of 7 analysts rating LENZ stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.